Literature DB >> 24162737

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.

J C Lambert, C A Ibrahim-Verbaas, D Harold, A C Naj, R Sims, C Bellenguez, A L DeStafano, J C Bis, G W Beecham, B Grenier-Boley, G Russo, T A Thorton-Wells, N Jones, A V Smith, V Chouraki, C Thomas, M A Ikram, D Zelenika, B N Vardarajan, Y Kamatani, C F Lin, A Gerrish, H Schmidt, B Kunkle, M L Dunstan, A Ruiz, M T Bihoreau, S H Choi, C Reitz, F Pasquier, C Cruchaga, D Craig, N Amin, C Berr, O L Lopez, P L De Jager, V Deramecourt, J A Johnston, D Evans, S Lovestone, L Letenneur, F J Morón, D C Rubinsztein, G Eiriksdottir, K Sleegers, A M Goate, N Fiévet, M W Huentelman, M Gill, K Brown, M I Kamboh, L Keller, P Barberger-Gateau, B McGuiness, E B Larson, R Green, A J Myers, C Dufouil, S Todd, D Wallon, S Love, E Rogaeva, J Gallacher, P St George-Hyslop, J Clarimon, A Lleo, A Bayer, D W Tsuang, L Yu, M Tsolaki, P Bossù, G Spalletta, P Proitsi, J Collinge, S Sorbi, F Sanchez-Garcia, N C Fox, J Hardy, M C Deniz Naranjo, P Bosco, R Clarke, C Brayne, D Galimberti, M Mancuso, F Matthews, S Moebus, P Mecocci, M Del Zompo, W Maier, H Hampel, A Pilotto, M Bullido, F Panza, P Caffarra, B Nacmias, J R Gilbert, M Mayhaus, L Lannefelt, H Hakonarson, S Pichler, M M Carrasquillo, M Ingelsson, D Beekly, V Alvarez, F Zou, O Valladares, S G Younkin, E Coto, K L Hamilton-Nelson, W Gu, C Razquin, P Pastor, I Mateo, M J Owen, K M Faber, P V Jonsson, O Combarros, M C O'Donovan, L B Cantwell, H Soininen, D Blacker, S Mead, T H Mosley, D A Bennett, T B Harris, L Fratiglioni, C Holmes, R F de Bruijn, P Passmore, T J Montine, K Bettens, J I Rotter, A Brice, K Morgan, T M Foroud, W A Kukull, D Hannequin, J F Powell, M A Nalls, K Ritchie, K L Lunetta, J S Kauwe, E Boerwinkle, M Riemenschneider, M Boada, M Hiltuenen, E R Martin, R Schmidt, D Rujescu, L S Wang, J F Dartigues, R Mayeux, C Tzourio, A Hofman, M M Nöthen, C Graff, B M Psaty, L Jones, J L Haines, P A Holmans, M Lathrop, M A Pericak-Vance, L J Launer, L A Farrer, C M van Duijn, C Van Broeckhoven, V Moskvina, S Seshadri, J Williams, G D Schellenberg, P Amouyel.   

Abstract

Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous studies; however, a large portion of the genetic risk for this disease remains unexplained. We conducted a large, two-stage meta-analysis of genome-wide association studies (GWAS) in individuals of European ancestry. In stage 1, we used genotyped and imputed data (7,055,881 SNPs) to perform meta-analysis on 4 previously published GWAS data sets consisting of 17,008 Alzheimer's disease cases and 37,154 controls. In stage 2, 11,632 SNPs were genotyped and tested for association in an independent set of 8,572 Alzheimer's disease cases and 11,312 controls. In addition to the APOE locus (encoding apolipoprotein E), 19 loci reached genome-wide significance (P < 5 × 10(-8)) in the combined stage 1 and stage 2 analysis, of which 11 are newly associated with Alzheimer's disease.

Entities:  

Mesh:

Year:  2013        PMID: 24162737      PMCID: PMC3896259          DOI: 10.1038/ng.2802

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  52 in total

1.  GWAS findings for human iris patterns: associations with variants in genes that influence normal neuronal pattern development.

Authors:  Mats Larsson; David L Duffy; Gu Zhu; Jimmy Z Liu; Stuart Macgregor; Allan F McRae; Margaret J Wright; Richard A Sturm; David A Mackey; Grant W Montgomery; Nicholas G Martin; Sarah E Medland
Journal:  Am J Hum Genet       Date:  2011-08-12       Impact factor: 11.025

2.  Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.

Authors:  Ana Griciuc; Alberto Serrano-Pozo; Antonio R Parrado; Andrea N Lesinski; Caroline N Asselin; Kristina Mullin; Basavaraj Hooli; Se Hoon Choi; Bradley T Hyman; Rudolph E Tanzi
Journal:  Neuron       Date:  2013-04-25       Impact factor: 17.173

3.  CAKbeta/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus.

Authors:  Y Huang; W Lu; D W Ali; K A Pelkey; G M Pitcher; Y M Lu; H Aoto; J C Roder; T Sasaki; M W Salter; J F MacDonald
Journal:  Neuron       Date:  2001-02       Impact factor: 17.173

4.  Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis.

Authors:  Jean-Charles Lambert; Benjamin Grenier-Boley; Vincent Chouraki; Simon Heath; Diana Zelenika; Nathalie Fievet; Didier Hannequin; Florence Pasquier; Olivier Hanon; Alexis Brice; Jacques Epelbaum; Claudine Berr; Jean-Francois Dartigues; Christophe Tzourio; Dominique Campion; Mark Lathrop; Philippe Amouyel
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  ProbABEL package for genome-wide association analysis of imputed data.

Authors:  Yurii S Aulchenko; Maksim V Struchalin; Cornelia M van Duijn
Journal:  BMC Bioinformatics       Date:  2010-03-16       Impact factor: 3.169

6.  Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.

Authors:  Lesley Jones; Peter A Holmans; Marian L Hamshere; Denise Harold; Valentina Moskvina; Dobril Ivanov; Andrew Pocklington; Richard Abraham; Paul Hollingworth; Rebecca Sims; Amy Gerrish; Jaspreet Singh Pahwa; Nicola Jones; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Britta Schürmann; Reinhard Heun; Heike Kölsch; Hendrik van den Bussche; Isabella Heuser; Oliver Peters; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panos Deloukas; Ammar Al-Chalabi; Christopher E Shaw; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Eckhard Rüther; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; John Hardy; Michael C O'Donovan; Michael J Owen; Julie Williams
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

7.  CRMP2 hyperphosphorylation is characteristic of Alzheimer's disease and not a feature common to other neurodegenerative diseases.

Authors:  Ritchie Williamson; Lidy van Aalten; David M A Mann; Bettina Platt; Florian Plattner; Lynn Bedford; John Mayer; David Howlett; Alessia Usardi; Calum Sutherland; Adam R Cole
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

8.  Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites.

Authors:  N Brouwers; C Van Cauwenberghe; S Engelborghs; J-C Lambert; K Bettens; N Le Bastard; F Pasquier; A Gil Montoya; K Peeters; M Mattheijssens; R Vandenberghe; P P De Deyn; M Cruts; P Amouyel; K Sleegers; C Van Broeckhoven
Journal:  Mol Psychiatry       Date:  2011-03-15       Impact factor: 15.992

9.  A genome-wide association study of hypertension and blood pressure in African Americans.

Authors:  Adebowale Adeyemo; Norman Gerry; Guanjie Chen; Alan Herbert; Ayo Doumatey; Hanxia Huang; Jie Zhou; Kerrie Lashley; Yuanxiu Chen; Michael Christman; Charles Rotimi
Journal:  PLoS Genet       Date:  2009-07-17       Impact factor: 5.917

10.  TREM2 variants in Alzheimer's disease.

Authors:  Rita Guerreiro; Aleksandra Wojtas; Jose Bras; Minerva Carrasquillo; Ekaterina Rogaeva; Elisa Majounie; Carlos Cruchaga; Celeste Sassi; John S K Kauwe; Steven Younkin; Lilinaz Hazrati; John Collinge; Jennifer Pocock; Tammaryn Lashley; Julie Williams; Jean-Charles Lambert; Philippe Amouyel; Alison Goate; Rosa Rademakers; Kevin Morgan; John Powell; Peter St George-Hyslop; Andrew Singleton; John Hardy
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

View more
  1731 in total

1.  Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.

Authors:  Santiago V Salazar; Timothy O Cox; Suho Lee; A Harrison Brody; Annabel S Chyung; Laura T Haas; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2018-12-05       Impact factor: 6.167

Review 2.  Genome-wide significant, replicated and functional risk variants for Alzheimer's disease.

Authors:  Xiaoyun Guo; Wenying Qiu; Rolando Garcia-Milian; Xiandong Lin; Yong Zhang; Yuping Cao; Yunlong Tan; Zhiren Wang; Jing Shi; Jijun Wang; Dengtang Liu; Lisheng Song; Yifeng Xu; Xiaoping Wang; Na Liu; Tao Sun; Jianming Zheng; Justine Luo; Huihao Zhang; Jianying Xu; Longli Kang; Chao Ma; Kesheng Wang; Xingguang Luo
Journal:  J Neural Transm (Vienna)       Date:  2017-08-02       Impact factor: 3.575

3.  Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease.

Authors:  Lei Yu; Lori B Chibnik; Gyan P Srivastava; Nathalie Pochet; Jingyun Yang; Jishu Xu; James Kozubek; Nikolaus Obholzer; Sue E Leurgans; Julie A Schneider; Alexander Meissner; Philip L De Jager; David A Bennett
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

4.  Exploring the epigenetics of Alzheimer disease.

Authors:  Bryan J Traynor; Alan E Renton
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

5.  Genetic variation in imprinted genes is associated with risk of late-onset Alzheimer's disease.

Authors:  Mamoonah Chaudhry; Xingbin Wang; Mikhil N Bamne; Shahida Hasnain; F Yesim Demirci; Oscar L Lopez; M Ilyas Kamboh
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

6.  PICALM rescues glutamatergic neurotransmission, behavioural function and survival in a Drosophila model of Aβ42 toxicity.

Authors:  Yifan Yu; Teresa Niccoli; Ziyu Ren; Nathaniel S Woodling; Benjamin Aleyakpo; Gyorgy Szabadkai; Linda Partridge
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

7.  Polygenic risk score analysis of pathologically confirmed Alzheimer disease.

Authors:  Valentina Escott-Price; Amanda J Myers; Matt Huentelman; John Hardy
Journal:  Ann Neurol       Date:  2017-08-09       Impact factor: 10.422

8.  An Alzheimer's Disease-Linked Loss-of-Function CLN5 Variant Impairs Cathepsin D Maturation, Consistent with a Retromer Trafficking Defect.

Authors:  Yasir H Qureshi; Vivek M Patel; Diego E Berman; Milankumar J Kothiya; Jessica L Neufeld; Badri Vardarajan; Min Tang; Dolly Reyes-Dumeyer; Rafael Lantigua; Martin Medrano; Ivonne J Jiménez-Velázquez; Scott A Small; Christiane Reitz
Journal:  Mol Cell Biol       Date:  2018-09-28       Impact factor: 4.272

9.  Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study.

Authors:  Thomas Polak; Martin J Herrmann; Laura D Müller; Julia B M Zeller; Andrea Katzorke; Matthias Fischer; Fabian Spielmann; Erik Weinmann; Leif Hommers; Martin Lauer; Andreas J Fallgatter; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

Review 10.  Microglia in Alzheimer's disease.

Authors:  Heela Sarlus; Michael T Heneka
Journal:  J Clin Invest       Date:  2017-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.